A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer

Lloyd Jones, M., Hummel, S., Bansback, N. and Orr, B. (2001) A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer. Technical Report. Core Research , Alton.

Abstract

Metadata

Authors/Creators:
  • Lloyd Jones, M.
  • Hummel, S.
  • Bansback, N.
  • Orr, B.
Copyright, Publisher and Additional Information: Copyright: Queen’s Printer and Controller of HMSO 2001 HTA reports may be freely reproduced for the purposes of private research and study and may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Violations should be reported to hta@soton.ac.uk Applications for commercial reproduction should be addressed to HMSO, The Copyright Unit, St Clements House, 2-16 Colegate, Norwich, NR3 1BQ
Keywords: Colorectal cancer, Colorectal neoplasms, Quality of life, Drug therapy, Clinical effectiveness, Cost effectiveness, Irinotecan, Oxaliplatin, Raltitrexed, Cisplatin, Cost benefit analysis, Systematic review
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield)
Depositing User: Diana Papaioannou
Date Deposited: 07 Dec 2006
Last Modified: 13 May 2015 00:31
Published Version: http://www.hta.ac.uk/1198
Status: Published
Publisher: Core Research
Identification Number: ISSN 1366-5278

Share / Export

Statistics